Robot-assisted retroperitoneal lymph node dissection in testicular cancer.
Robotic surgical techniques are now being applied in the setting of retroperitoneal lymphadenectomy (RPLND) for testicular cancer. While laparoscopic RPLND has not been widely accepted, reports of robot assisted RPLND (RARPLND) are emerging. This manuscript will review the application of RPLND for testicular cancer, evolution of minimally invasive techniques, the controversies, and current status of RARPLND.
Mayo Clinic, Phoenix, Arizona.
Haidar M
HM
Abdul-Muhsin
Naval Medical Center San Diego, Department Urology, San Diego, California.
James O
JO
L'esperance
Naval Medical Center San Diego, Department Urology, San Diego, California.
Kimberly
K
Fischer
University of North Carolina, Chapel Hill, North Carolina.
Michael E
ME
Woods
Swedish Medical Center, Swedish Urology Group, Seattle, Washington.
James R
JR
Porter
Mayo Clinic, Phoenix, Arizona.
Erik P
EP
Castle
D017024:Chemotherapy, Adjuvant; D061887:Conversion to Open Surgery / Q000706:statistics & numerical data; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods; D007902:Length of Stay; D008197:Lymph Node Excision / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D008297:Male; D061646:Operative Time; D012187:Retroperitoneal Space; D065287:Robotic Surgical Procedures / Q000009:adverse effects / Q000379:methods; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000601:surgery*
RPLND; lymph node dissection; robotic surgery; testicular cancer